Oruka Therapeutics, Inc. Class of Warrant or Right, Outstanding
Oruka Therapeutics, Inc. (ORKA) had Class of Warrant or Right, Outstanding of 135.86 thousand shares as of 2019-12-31, per its 10-K filed 2020-02-18.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2020-02-18
- 2019-12-31: Class of Warrant or Right, Outstanding 135.86K shares.
- 2019-09-30: Class of Warrant or Right, Outstanding 135.86K shares.
- 2019-06-30: Class of Warrant or Right, Outstanding 135.86K shares.
- 2019-03-31: Class of Warrant or Right, Outstanding 135.86K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2019-12-31 | 135.86K shares 10-K · filed 2020-02-18 |
| 2019-09-30 | 135.86K shares 10-Q · filed 2019-11-06 |
| 2019-06-30 | 135.86K shares 10-Q · filed 2019-08-01 |
| 2019-03-31 | 135.86K shares 10-Q · filed 2019-05-08 |
| 2018-12-31 | 2.67M shares 10-K · filed 2019-02-27 |
| 2018-09-30 | 2.67M shares 10-Q · filed 2018-11-14 |
| 2018-06-30 | 2.67M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 3.62M shares 10-Q · filed 2018-05-08 |
| 2017-12-31 | 3.63M shares 10-K · filed 2018-03-22 |
| 2017-09-30 | 3.66M shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 3.66M shares 10-Q · filed 2017-08-03 |
| 2017-03-31 | 3.69M shares 10-Q · filed 2017-05-15 |
| 2016-12-31 | 3.69M shares 10-K · filed 2017-03-21 |
| 2016-09-30 | 3.72M shares 10-Q · filed 2016-11-14 |
| 2016-06-30 | 3.72M shares 10-Q · filed 2016-08-09 |
| 2016-03-31 | 3.74M shares 10-Q · filed 2016-05-11 |
| 2015-12-31 | 3.74M shares 10-K · filed 2016-03-17 |
| 2015-09-30 | 3.74M shares 10-Q · filed 2015-11-12 |
| 2015-06-30 | 26.18M shares 10-Q · filed 2015-08-11 |
| 2015-03-31 | 9.37M shares 10-Q · filed 2015-05-12 |
| 2014-12-31 | 9.37M shares 10-K · filed 2015-03-19 |
| 2014-09-30 | 9.40M shares 10-Q · filed 2014-11-12 |
| 2014-06-30 | 9.40M shares 10-Q · filed 2014-08-13 |
| 2014-03-31 | 9.40M shares 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |